News

Too much alcohol can be deadly in the summer heat, the National Institute on Alcohol Abuse and Alcoholism warns, as 1 in 6 ...
Feeding wild elephants might seem kind, but a new study by researchers at the University of California San Diego warns that ...
The FDA called for Sarepta Therapeutics to stop shipping its muscular dystrophy gene therapy, but the company said no.
It's important to stay informed about recalls, because doing so truly impacts your life. Of course, the sooner you know about ...
More than 67,000 cases of Power Stick deodorants are being recalled due to safety concerns tied to manufacturing practices, ...
FDA published a press release written by FDA Commissioner Marty Makary that highlighted his efforts to “make food healthier ...
FDA outlines both short-term and long-term goals within the letter. In the short term, FDA plans to create a “centralized, ...
The FDA has issued a voluntary recall of over 67,000 cases of Power Stick roll-on deodorants due to deviations from ...
Supporters believe that FDA approval will make the drug more accessible. Right now, traditional psilocybin therapy offered at healing centers in the state is not covered by insurance.
A.P. Deauville recalled 67,000 cases of Power Stick deodorant on July 10, 2025, for FDA-noted cGMP violations, affecting ...
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
CHICAGO - A recall is underway for tens of thousands of cases of Power Stick antiperspirant deodorant, according to the FDA; ...